Basic Information

Gene symbol E2F1 Synonyms E2F-1, RBAP1, RBBP3, RBP3 Type of gene protein-coding
Gene perturbation-related omics dataset PerturbAtlas | PertOrg
Description E2F transcription factor 1

GTO ID GTC3980
Trial ID NCT01844661
Disease Solid Tumor
Altered gene E2F1
Therapeutic/Target gene Therapeutic gene
TherapyDNA oncolytic virus
Treatment CELYVIR
PhasePhase1|Phase2
Recruitment statusCompleted
TitlePhase 1 Trial of Celyvir in Children and Adults With Metastatic and Refractory Solid Tumors.
Year2013
CountrySpain
Company sponsorHospital Infantil Universitario Niño Jesús, Madrid, Spain
Other ID(s)EudraCT2008-000364-16
Vector information
Vectorhuman mesenchymal stem cells
ConstructAd5-E2F-delta24-RGD
Vector typethird-generation retargeted oncolytic adenovirus
Viral genome modificationTo insert the Kozak sequence before E1A, a KpnI fragment from pShuttle-DM-E2F-Δ-24, containing the E2F promoter and E1A, was subcloned into pGEM-3Z (Promega). This plasmid was then used to replace the E1A translation start site with oligonucleotides containing the Kozak sequence. The KpnI fragment, containing the E2F-E1A modified with the Kozak sequence, was returned to pShuttle-DM-E2F-Δ-24 to generate pShuttle-DM-E2F-KD24. Finally, pShuttle-DM-E2F-Δ-24 was recombined by homologous recombination with pVK503, which contains the complete Ad5 genome with an RGD-modified fiber.
Additional featureMesenchymal allogenic cells

Clinical Result

Cohort 1
Administration route intravenous infusion
Pts 20
Age Child, Adult, Older_Adult
References PMID: 33737338 | PMID: 32053771

Relationship Graph

Overview of Knowledge Graph